Area of research
Molecular Biology · Surgery
Research interest
Research focused on Ovarian cancer and Immunohistochemistry, with related work in Cancer research, Apoptosis, Immunotherapy. Notable publications include 'Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant', 'Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy', and 'Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model'.
Synergizing Ferroptosis Suppressor Protein 1 Gene Silencing and Photodynamic Therapy Based on Photosensitive Lipid Nanoparticles for Colon Cancer Immunotherapy
In vivo CRISPR screens identify<i>Mga</i>as an immunotherapy target in triple-negative breast cancer
Bromodomain and extraterminal (BET) proteins: biological functions, diseases and targeted therapy
CBL0137 activates ROS/BAX signaling to promote caspase-3/GSDME-dependent pyroptosis in ovarian cancer cells
An enzyme-responsive and transformable PD-L1 blocking peptide-photosensitizer conjugate enables efficient photothermal immunotherapy for breast cancer
Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer
LOC100130075 Promotes Cervical Cancer Progression by Activating MDM2 Transcription through E2F1
The arsenal of TP53 mutants therapies: neoantigens and bispecific antibodies
Deubiquitinating Enzymes Orchestrate the Cancer Stem Cell-Immunosuppressive Niche Dialogue: New Perspectives and Therapeutic Potential
Identification and Validation of Immune-Related Gene for Predicting Prognosis and Therapeutic Response in Ovarian Cancer
Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
E2F1/2/7/8 as independent indicators of survival in patients with cervical squamous cell carcinoma
Integrated analysis of a competing endogenous RNA network reveals an 11-lncRNA prognostic signature in ovarian cancer
Circulating tumor cells in precision oncology: clinical applications in liquid biopsy and 3D organoid model
Expression of Nemo-like kinase in cervical squamous cell carcinoma: a clinicopathological study
Tumor necrosis factor α–induced protein 8 expression as a predictor of prognosis and resistance in patients with advanced ovarian cancer treated with neoadjuvant chemotherapy
miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A)
NUCKS nuclear elevated expression indicates progression and prognosis of ovarian cancer
Correlation of Collagen Triple Helix Repeat Containing1 Overexpression with Lymph Node and Peritoneal Metastasis in Epithelial Ovarian Cancer
Increased NUCKS expression is a risk factor for poor prognosis and recurrence in endometrial cancer.
PubMed Central 2015cited by 17position: middle